Revance rolls out a price drop for Daxxify as it tries to challenge AbbVie's Botox

Revance rolls out a price drop for Daxxify as it tries to challenge AbbVie's Botox

Source: 
Fierce Pharma
snippet: 

With a new cosmetic dermal filler that works twice as long as AbbVie’s Botox, Nashville, Tennessee, company Revance thought it could capture what it termed the “prestige market.” That, of course, came with a premium price for its botulinum toxin treatment.